Bridge Bank — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Noctrix Healthnoctrixhealth.comAug 2025 · $33.5M
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Co-investorsAngelini VenturesBlue Venture FundsOrbiMedTreo Ventures, LlcZühlke VenturesSandbox Clinical Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.